Wayland Group Corp. (CSE:WAYL; FWB:75M; OTCQB:MRRCF) recently announced a letter of intent (LOI) with International Cannabis Corp. (ICC) (CSE:WRLD.U). Under the potential agreement, Wayland Group would sell 49.9 percent of the company’s international asset portfolio and receive 300 million shares of ICC at a price of $0.43 per share, valuing Wayland’s international business at approximately US$258 million.

Under the supply agreement, Wayland Group will supply ICC with 10,000 kilograms of EU-GMP-certified product each year for a total of three years. Wayland Group’s international business will also be held in a subsidiary jointly owned by the two parties.


In a recent interview on MidasLetter Live, Wayland Group CEO Ben Ward discussed the agreement and addressed how it will provide the company with access to a much broader distribution network across Europe.

“Selling half of the business to ICC gets us a broader framework and completes our vertical integration that we’ve been seeking across all the aspects in the value chain,” he said. “So we now have a EU GMP compliant pharmaceutical manufacturing facility in Greece, a federal license in Denmark, which we’ll be developing to give us certainty of product for the EU outside of Canada, and then it also gives us broad distribution.”

In discussing the agreement, Ward also addressed the steps that still need to be taken in order to close the deal. “We’ve already done the due diligence in Greece; we’re impressed with the facilities and the operations there, and we’ll be moving ahead with due diligence in Bulgaria, Denmark, and then in Poland, as well. Those are the places that we have yet to see. Our team was in Colombia last week, so there is really little left to do on the diligence side of things.”

To see the full interview, click here.

Click here to connect with Wayland Group Corp. (CSE:WAYL, FWB:75M, OTCQB:MRRCF) for an Investor Presentation.

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/clean-tech/

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less